Skip to content

Prospective Observational Study on Stratified Treatment with Immunoglobulin plus Steroid Efficacy and Safety for Kawasaki Disease

Prospective Observational Study on Stratified Treatment with Immunoglobulin plus Steroid Efficacy and Safety for Kawasaki Disease - Post RAISE

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000007133
Enrollment
1500
Registered
2012-02-01
Start date
2012-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kawasaki disease

Interventions

None listed

Sponsors

Tokyo Metropolitan Children's Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) 5 or 6 major symptoms of Kawasaki disease 2) 4 major symptoms with 4 or more days of fever 3) 3 major symptoms with 5 or more days of fever 4) 1 or 2 major symptoms with coronary artery lesions

Exclusion criteria

Exclusion criteria: 1)Similar findings are present, but Kawasaki disease is unlikely 2) 4 major symptoms with 3 or less days of fever 3) 3 major symptoms with 4 or less days of fever 4) 1 or 2 major symptoms without coronary artery lesions

Design outcomes

Primary

MeasureTime frame
Prevalence of coronary artery lesions one month after initial treatment

Countries

Japan

Contacts

Public ContactKoichi Miyata

Tokyo Metropolitan Children's Medical Center Department of Cardiology

masaru10miura@gmail.com0423005111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026